Recent Biotech, Cannabis, Food & Drug, & Pharma Administration News

Publication Date Organization
May
2
2022
 OIG Says that Increasing Use of Biosimilars Could Reduce Part D Spending Mintz
May
2
2022
 Litigation Minute: Defending Consumer Class Action Claims Involving PFAS K&L Gates LLP
May
2
2022
 New Draft Guidance on FDA’s Accredited Third-Party Certification Program Keller and Heckman LLP
May
1
2022
 Northern District of Illinois Decisions Find Access or Disclosure Exclusion Precludes Coverage for BIPA Claims, Creating a New Split in the District Wilson Elser Moskowitz Edelman & Dicker LLP
Apr
29
2022
 FDA Issues Draft Action Levels for Lead in Juice Keller and Heckman LLP
Apr
29
2022
 International Cooperation under China’s Proposed Implementing Rules for Human Genetic Resources Management Sheppard, Mullin, Richter & Hampton LLP
Apr
29
2022
 How Pharmacies Can Defend Against PBM Audits Oberheiden P.C.
Apr
29
2022
 New Guidance for Management of Biological Foodborne Outbreaks, and Identification of CCPs Keller and Heckman LLP
Apr
28
2022
 FDA Updates FSVP Guidance on UFI Keller and Heckman LLP
Apr
28
2022
 India: Another Booming Market for Alternative Proteins in Asia Keller and Heckman LLP
Apr
28
2022
 The Metaverse: Alcohol Beverage Industry’s Next Marketing Frontier? ArentFox Schiff LLP
Apr
27
2022
 Baby Food Lawsuit Dismissed as “Simply Speculative” Keller and Heckman LLP
Apr
27
2022
 California Bill Proposes to Prohibit Employment Discrimination Against Marijuana Users Ogletree, Deakins, Nash, Smoak & Stewart, P.C.
Apr
26
2022
 Medicaid Best Price 101: A Review of Medicaid Best Price Policy and New CMS Guidance on Medicaid Best Price Reporting for Value Based Purchasing Arrangements Mintz
Apr
26
2022
 What Municipalities Need to Know in 2022: Newly Signed Pennsylvania Legislation Strassburger McKenna Gutnick & Gefsky
Apr
26
2022
 What’s Brewing at Starbucks? Labor Law Litigation Over Employee Terminations Barnes & Thornburg LLP
Apr
26
2022
 FDA Urged to Make Changes to its Food Recall Activities Keller and Heckman LLP
Apr
25
2022
 Morningstar Farms “Veggie” Product Labeling Complaint Dismissed Keller and Heckman LLP
Apr
25
2022
 Navigating the Cannabis Fog: Litigation Ensues Over Legality of Delta-8 and Delta-10 Bradley Arant Boult Cummings LLP
Apr
25
2022
 FDA Publishes Final Guidance for Industry on Drug Products, Including Biological Products, that Contain Nanomaterials Bergeson & Campbell, P.C.
Apr
22
2022
 With Proposal to Cap Drug Price Increases, Massachusetts Once Again Takes Center Stage in the Drug Pricing Debate Mintz
Apr
22
2022
 FDA Releases Draft Guidance on NAC Enforcement Keller and Heckman LLP
Apr
22
2022
 Letter from the Editors: What a Long, Strange Trip It’s Been Bradley Arant Boult Cummings LLP
Apr
21
2022
 Cannabis Goes to the Metaverse, Creating New Opportunities and Business Questions ArentFox Schiff LLP
Apr
21
2022
 Don’t Tell Me This Town Ain’t Got No Heart: Mississippi’s Attorney General Opines on a City’s Ability to Regulate Medical Cannabis Businesses Bradley Arant Boult Cummings LLP
Apr
21
2022
 CSPI Criticizes FDA Allergen Guidance Keller and Heckman LLP
Apr
21
2022
 Insurance Coverage Considerations for Tribal Cannabis Businesses Van Ness Feldman LLP
Apr
21
2022
 Uncertainty Abounds as EPA Works to Reach Any of The Destinations on Its PFAS Road Map but States Press On. Mintz
Displaying 3613 - 3640 of 12574
Subscribe to The 10 Latest Biological, Life Sciences, and Cleantech Law Articles
 
NLR Logo
We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up for any (or all) of our 25+ Newsletters.

 

Sign Up for any (or all) of our 25+ Newsletters